Oric Pharmaceuticals, Inc. (ORIC) › Net IncomeOric Pharmaceuticals, Inc. (ORIC) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$21.36M2019: -$26.88M2020: -$73.70M2021: -$78.72M2022: -$89.12M2023: -$100.70M2024: -$127.85M2025: -$129.47M-$129.47M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$129.47M-1.3%2024-$127.85M-27.0%2023-$100.70M-13.0%2022-$89.12M-13.2%2021-$78.72M-6.8%2020-$73.70M-174.2%2019-$26.88M-25.8%2018-$21.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share